Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - montelukast sodium, quantity: 4.16 mg - tablet, chewable - excipient ingredients: microcrystalline cellulose; iron oxide red; magnesium stearate; mannitol; croscarmellose sodium; aspartame; flavour - -prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. ,-symptomatic treatment of seasonal allergic rhinitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - montelukast sodium, quantity: 10.4 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; macrogol 6000; iron oxide yellow; hypromellose; titanium dioxide; hyprolose; magnesium stearate; iron oxide red; lactose monohydrate; microcrystalline cellulose - -prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. ,-symptomatic treatment of seasonal allergic rhinitis.

United States - English - NLM (National Library of Medicine)

{preferred pharmaeutials inc. - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 5 mg -          montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.             montelukast sodium is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. montelukast sodium is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older. risk summary            available  data  from  published  prospective  and  retrospective  cohort  studies  over decades  with montelukast use in pregnant women have not established a drug-associated risk of major birth defects [see data] . in animal reproduction studies, no adverse developmental effects were observed with oral administration of montelukast to pregnant rats and rabbits during organogenesis at doses approximately 100 and 110 times, respectively, the maximum recommended human daily oral dose (mr

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - montelukast sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - montelukast sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - montelukast sodium -

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - montelukast - film-coated tablet - 10 milligram(s) - leukotriene receptor antagonists; montelukast

Malta - English - Medicines Authority

accord healthcare limited - montelukast - chewable tablet - montelukast 4 mg - drugs for obstructive airway diseases

Malta - English - Medicines Authority

accord healthcare limited - montelukast - chewable tablet - montelukast 5 mg - drugs for obstructive airway diseases

Malta - English - Medicines Authority

accord healthcare limited - montelukast - film-coated tablet - montelukast 10 mg - drugs for obstructive airway diseases